Menu Search
Equities

Mauna Kea Technologies SA

ALMKT:PAR

Mauna Kea Technologies SA

Actions
Health CareMedical Equipment and Services
  • Price (EUR)0.187
  • Today's Change0.007 / 3.89%
  • Shares traded390.12k
  • 1 Year change-58.72%
  • Beta1.3123
Data delayed at least 15 minutes, as of Nov 14 2024 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Mauna Kea Technologies SA grew revenues 40.13% from 7.48m to 10.48m while net income improved from a loss of 11.18m to a smaller loss of 3.73m.
Gross margin11.48%
Net profit margin-159.20%
Operating margin-120.59%
Return on assets-56.61%
Return on equity--
Return on investment-142.92%
More ▼

Cash flow in EURView more

In 2023, Mauna Kea Technologies SA increased its cash reserves by 154.03%, or 4.83m. Cash Flow from Financing totalled 5.96m or 56.86% of revenues. In addition the company used 754.00k for operations while cash used for investing totalled 354.00k.
Cash flow per share-0.2045
Price/Cash flow per share--
Book value per share-0.3148
Tangible book value per share-0.3416
More ▼

Balance sheet in EURView more

Mauna Kea Technologies SA appears to have a weak balance sheet, highlighted by its negative owner's equity. Additionally, although this company's debt load outweighs its assets, its Interest Coverage ratio, at 4.289200000000000, shows that it is comfortably able to pay interest expenses out of operating profits.
Current ratio0.9418
Quick ratio0.6603
Total debt/total equity--
Total debt/total capital3.50
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.